Hierarchical endpoints and win statistics for geromedicine trials

💲 Paywalled: This content may require a subscription. Manage paywalled content settings on Scour.

Geroscience has advanced rapidly, yet its clinical translation remains limited. A central barrier is the lack of trial outcomes that capture the multidimensional effects of geroprotective interventions while meeting clinical and regulatory standards. Mortality is objective and regulatorily salient b…

View Post on Scour ↗

More from Nature on Scour.